Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Code 1 Supply Named Distributor for SCoV-2 Ag Detect™ Rapid Test for COVID-19 from InBios

Code 1 Supply

Code 1 Supply, a leading distributor of best-in-class medical diagnostics, brand-name supplies and equipment and provider of CPR training equipment and student materials, has been named distributor of an innovative new point-of-care COVID-19 test, the SCoV-2 Ag Detect ™ Rapid Test from InBios International, Inc. The SCoV-2 Ag Detect ™ Rapid Test is a patent-pending lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleoprotein antigen in direct nasal swab specimens. The point-of-care test can be used to evaluate both symptomatic and asymptomatic individuals. The test can be used for those who are suspected of COVID-19 by their healthcare provider within five days of symptom onset or for individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests. The kit contains 50 tests and swabs, positive and negative controls and can be stored at room temperature. “As more Americans receive their COVID-19 vaccine, we are seeing a return to normalcy, which must still be supported by testing,” said Matt Regan, CEO at Code 1 Supply. “We are proud to partner with InBios to supply the SCoV-2 Ag Detect ™ Rapid Test nationwide to quickly and easily detect proteins from COVID-19 infection.” Code 1 Supply delivers best-in-class medical diagnostics and brand-name supplies and equipment when and where they are needed most. Code 1 Supply carries innovative next-generation rapid diagnostics for accurate, low-cost, high volume COVID-19 testing and provides exceptional customer service and expertise. They have been a leader in COVID-19 testing since the beginning of the pandemic, helping to supply medical professionals with sufficient testing supplies and equipment worldwide. Now, with FDA Emergency Use Authorization of the SCoV-2 Ag Detect ™ Rapid Test, Code 1 Supply is prepared to ship millions of tests to fulfill ongoing needs. “We are pleased to collaborate with Code 1 Supply as our e-commerce distribution partner to quickly expand accessibility and extend our reach to POC providers with a much simpler option for rapid antigen detection than they may have had access to previously,” said Estela Raychaudhuri, President, at InBios. “Code 1 Supply’s superior customer service and easy to navigate ordering process is an important part of providing access to incredibly accurate diagnostic tests that make a meaningful difference in people’s lives as they return to their jobs, schools and other ways of life.” The point-of-care SCoV-2 Ag Detect ™ Rapid Test is available through Code 1 Supply. To learn more about how Code 1 Supply can support your COVID-19 testing needs, please visit www.code1supply.com/inbiosagdetect. The SCoV-2 Ag Detect ™ Rapid Test has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner. About Code 1 Supply Code 1 Supply is an international distributor of best-in-class medical diagnostics, brand-name supplies, and equipment, and a leading provider of CPR training equipment and student materials. Representing the most trusted and respected manufacturers of medical diagnostics, supplies and equipment, Code 1 Supply is committed to providing innovative products and outstanding services at the best prices. We are proud to be the medical supply partner for healthcare providers, hospitals, urgent care centers, businesses and communities worldwide. For more information, visit www.code1supply.com. About InBios InBios International Inc. specializes in the design, development and manufacture of diagnostic assays for emerging infectious diseases and biothreats. Located in Seattle, WA, InBios offers superior quality products which are accurate, easy to use and cost effective. InBios is GMP compliant, FDA registered, USDA licensed and ISO 13485:2016 certified. For more information, visit http://www.inbios.com. # # # Contact Details SVM PR and Marketing Rita Murphy +1 774-454-1516 rita.murphy@svmpr.com Company Website https://www.code1supply.com/

June 17, 2021 10:42 AM Eastern Daylight Time

New Markets Tax Credit Coalition Releases 2021 NMTC Progress Report

New Markets Tax Credit Coalition

The New Markets Tax Credit Coalition today released its 2021 New Markets Tax Credit (NMTC) Progress Report, the seventeenth edition of the report—providing analysis of NMTC activities in 2020. The report was prepared by the NMTC Coalition, a national membership organization of Community Development Entities (CDEs) and investors organized to advocate on behalf of the NMTC. Every year since 2005, the NMTC Coalition surveys CDEs on their work delivering billions of dollars to businesses, creating jobs, and rejuvenating the parts of the country that have been left behind. The annual NMTC Progress Report presents the findings of the CDE survey and provides policymakers and practitioners with the latest trends and successes of the NMTC. "The Coalition's annual survey asks CDEs to report on the deployment of their allocation, investor trends, and a variety of community impact metrics," said Yvette Ittu, NMTC Coalition Board Chair and the President of Cleveland Development Advisors, a CDE in Cleveland, Ohio. "The findings clearly demonstrate the continued improvement and refinement of the program's efficiency and impact in low-income communities. Two decades after its introduction, the NMTC is no longer simply just a tool for delivering investment – instead, it has become one of the federal government's most effective tools for job creation and economic stabilization." Report highlights include: CDEs used $2.9 billion in NMTC allocation in 2020 to finance 272 NMTC projects in 48 states, Puerto Rico and the District of Columbia, amounting to $5.5 billion in total project investment to low-income communities. This financing resulted in the creation of 45,090 total jobs, including 28,322 permanent full-time-equivalent jobs and 16,768 construction jobs. Across 46 states and territories, CDEs rehabilitated or constructed 15.4 million square feet of space in 2020, thanks to NMTC financing. 82 projects expanded healthcare access in 2020 for 1.3 million patients. Healthcare projects included 41 Federally Qualified Health Centers and free clinics. 188 million meals were provided by food banks, food pantries, and community food projects financed in a year marked by an increase in food insecurity. More than 84,000 children in schools, youth programs and childcare centers were served. NMTC financing supported 152 manufacturing and industrial businesses with loans for working capital, new equipment, and 5.5 million sq. ft. of new space, often through incubators and multi-business facilities, creating 9,298 manufacturing jobs. 61 percent of mixed-use projects included at least one community facility, nonprofit, or social service component. Those new community resources add up to over 408 nonprofit facilities, health centers, childcare centers, libraries, community centers, and other community facilities. 85 percent of projects were in severely distressed communities. Sixty CDEs participated in the 2021 survey and provided data on their progress raising capital, lending, and investing in 2020 with the NMTC. The survey findings show that competition for credits continues to drive gains in efficiency. "Year after year, the data shows the NMTC not only delivers an unprecedented level of capital to low-income rural and urban communities, but it also creates much-needed jobs—helping individuals and families thrive and, in turn, grows those local economies where they live and work. In fact, since 2003, the NMTC has created more than one million jobs. Communities that were already struggling have been hit hard by the COVID-19 pandemic and need this important incentive for community revitalization now more than ever," said Coalition spokesperson Bob Rapoza. The report showcases the importance of the NMTC in providing more than two decades worth of patient, flexible capital to businesses and projects located in distressed rural and urban communities, thereby creating jobs and growing business opportunities. The NMTC financing ranges from more traditional industry and community sectors to new and cutting-edge technology. Projects and businesses that benefited from the Credit in the past year include manufacturing, healthcare, schools, and many others supporting childcare, youth, and families. Rapoza notes, "This report is further proof that the NMTC is working and Congress should expand and make the Credit permanent. It has the potential to positively impact communities across the country for years to come." About New Markets Tax Credit Program The New Markets Tax Credit (NMTC) was enacted in 2000 in an effort to stimulate private investment and economic growth in low-income urban neighborhoods and rural communities that lack access to the patient capital needed to support and grow businesses, create jobs, and sustain healthy local economies. Since its inception, the NMTC has generated more than one million jobs. Today, due to the NMTC, nearly $110 billion is hard at work in underserved communities in all 50 states, the District of Columbia, and Puerto Rico. For more information, visit www.NMTCCoalition.org. Contact Details Greg Wilson +1 571-239-7474 greg@curleycompany.com Company Website http://nmtccoalition.org/

June 17, 2021 09:00 AM Eastern Daylight Time

American Kidney Fund Applauds Introduction of the CARE for All Kidneys Act of 2021

American Kidney Fund

The American Kidney Fund (AKF) applauds Reps. Lisa Blunt Rochester (D-DE) and Brad Wenstrup (R-OH) for introducing the Coordination, Accountability, Research and Equity for All Kidneys Act of 2021, also known as the CARE for All Kidneys Act of 2021 (H.R. 3893). The bill would create a national action plan to address kidney disease in historically underserved populations, including minority and rural communities. LaVarne A. Burton, president and CEO of the American Kidney Fund, today issued this statement: “Kidney disease is one of the top 10 leading causes of death in the United States. Communities of color are disproportionately impacted by kidney failure, and underserved and rural communities face issues accessing health care. This important bill will pinpoint the issues that have created such a burden of kidney disease in these communities and will develop steps needed to prevent kidney disease, delay progression to kidney failure and increase the number of kidney transplants. “People living in underserved and rural communities have long faced challenges accessing health insurance, primary care, preventive care and pre-dialysis nephrology care. AKF is proud to have worked closely with Reps. Blunt Rochester and Wenstrup to develop a bill that aims to improve the health care delivery system, making it more equitable, accessible and inclusive, and to ensure high quality care for all kidney disease patients. “The CARE for All Kidneys Act of 2021 would create a national action plan that brings together key stakeholders, including the National Institutes of Health (NIH), the National Institute of Diabetes and Digestive and Kidney Diseases at NIH and the Centers for Disease Control and Prevention to address health disparities in kidney disease. The bill would support initiatives like expanding ongoing kidney disease research and addressing lower kidney transplantation rates in underserved communities. “This legislation is vital in addressing health disparities, improving the social determinants of health in the U.S. and ensuring that all kidney patients have access to the care they need. The introduction of this bill is just the first step. AKF is urging other members of Congress to cosponsor this important legislation to help it advance.” About the American Kidney Fund The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator and the Platinum Seal of Transparency from GuideStar. For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn. Contact Details American Kidney Fund Elissa Blattman +1 301-984-6644 eblattman@kidneyfund.org Company Website http://www.kidneyfund.org/

June 17, 2021 09:00 AM Eastern Daylight Time

Cyvatar Raises an Additional $9 Million in Series A Round

Cyvatar

Cyvatar today announced that it has raised $9 million as part of its Series A financing to help scale and serve its rapidly growing customer base and continue to drive the adoption of its innovative cybersecurity-as-a-service (CSaaS) model. Escalating cybersecurity breaches and the need to address vulnerabilities across systems, networks, and apps fuel the security services market, expected to reach $193 billion by 2028. Additionally, the growth in hybrid and remote workers coupled with unsecured and unpatched BYOD devices further underscores the need for on-demand cybersecurity resources that include human talent, proven processes, and best-of-breed technology delivered from a single intuitive platform. Cyvatar has grown more than 200% since its debut in October. ATX Venture Partners led the round with additional participation from existing customer CORTEC and longtime Cyvatar investor Bill Wood Ventures. Cyvatar closed a $3 million seed round late last year, bringing the total amount raised over the last eight months to $12 million. “We’ve seen fundraising explode in the security space, in part as a result of the raft of ransomware, email compromise, and phishing attacks that have made people more aware of the problem and increased the need to fix it quickly and effectively,” said Chris Shonk, partner at ATX Venture Partners. “Cyvatar is an exciting addition to our dynamic portfolio and a natural fit alongside our other rapidly growing organizations. No other company we evaluated solves the problems of cybersecurity like Cyvatar. With Cyvatar CSaaS, security becomes as effortless as turning on the lights. There’s no better value for customers.” Cyvatar CSaaS offers security in a box for organizations of any size and any level of cybersecurity expertise--already more than 150 platform members have started the security journey with Cyvatar. Its mature sales and marketing engine makes it easy for new members to join and offers ongoing education and support for existing customers to continuously remediate evolving threats, safeguard critical systems, and boost compliance scores. "I can tell you that after implementing just three Cyvatar solutions, our security confidence is a lot stronger than it was before and our company as a whole is far more secure,” said Brent Fanguy, vice president of technology at CORTEC. “We applaud Cyvatar for pricing by employee count because it’s so easy to calculate and fit into our budget -- no counting servers or workstations, which is a nightmare. Cyvatar has delivered consistent value from our security spend, and we look forward to continuing to grow our partnership with them.” Whether customers need to speed their sales cycles, remediate after a breach, prevent future incursions, or respond to a third-party risk assessment, Cyvatar helps them achieve superior business outcomes every day. Click HERE to get started free and learn more about how Cyvatar is making cybersecurity effortless for every business. About Cyvatar Cyvatar is committed to effortless cybersecurity for everyone. As the industry’s first subscription-based, cybersecurity-as-a-service (CSaaS) company, it’s our mission to transform the way the security industry builds, sells, and supports cyber solutions. We empower our members to achieve successful outcomes by providing expert advisors, proven technologies, and a strategic process roadmap to guarantee results that map to their business drivers. Our approach is rooted in proprietary ICARM (installation, configuration, assessment, remediation, maintenance) methodology that delivers smarter, measurable security solutions for superior compliance and cyber-attack protection faster and more efficiently, all at a fixed monthly price. And because we’re a subscription, members can cancel anytime. Cyvatar is a global organization with operations around the world. Begin your journey to security confidence at cyvatar.ai and follow us on Facebook, Instagram, LinkedIn, Twitter, and YouTube. About ATX Venture Partners ATX Venture Partners is an early-stage venture capital firm specializing in the South-Central US. The firm’s seed and Series A investments focus on software-as-a-service, IoT, e-commerce, AI, frontier commercial technologies and mobile applications. ATX Venture Partners brings institutional-grade funding, process and rigor to early-stage venture capital investments, and is the partner to propel portfolio companies forward to larger growth capital. The firm was founded in 2014 and is based in Austin, Texas. Visit www.atxventurepartners.com, and follow them on Twitter, Facebook, and LinkedIn. Contact Details Cyvatar KC Higgins +1 303-434-8163 kc@cyvatar.ai ATX Ventures Meg Brigman +15127666462 meg@atxventurepartners.com Company Website https://cyvatar.ai/

June 17, 2021 07:00 AM Eastern Daylight Time

Image

CDFI Coalition Praises Biden Administration and Congress for Release of Rapid Release Funding for CDFIs.

CDFI Coalition

The CDFI Coalition applauds the release of $1.25 billion in emergency funding for Community Development Financial Institutions (CDFIs), which will use these new resources to provide patient capital and technical assistance to businesses and projects in low-income rural and urban communities. “ Our mission is to encourage fair access to financial resources for America’s underserved people and communities,” said John Holdsclaw IV, President of the CDFI Coalition and Executive Vice President of the National Cooperative Bank. “The hard work and efforts of our CDFI Coalition members have forged an achievement today that will pay dividends across underserved, hard-hit communities and businesses. I’m proud that our voices brought action at the highest levels of government to the needs that exist.” Over the last 18 months, as the coronavirus was upending small community businesses, the CDFI Coalition worked with Congress to support and enhance the work of CDFIs in low- and moderate-income communities and communities of color. Congress ultimately provided new resources for CDFIs through a Paycheck Protection Act (PPP) set-aside and $12 billion in new funding for the CDFI Fund. The idea to significantly boost support for CDFIs originated in the House Appropriations Committee in 2020. HR 6800, The HEROS Act, included $1 billion in financial assistance for CDFIs to support businesses and communities impacted by the coronavirus pandemic. Later, in the December 2020 coronavirus relief package, the House provision grew to $1.25 billion in financial assistance for CDFIs, which was awarded Tuesday by the Treasury Department through the Rapid Response Program. The December 2020 legislation also included $1.75 billion through the Emergency Support and Minority Lending Program to support financial services in communities of color, as well as an additional $9 billion for the Emergency Capital Investment Program to support capital and services in low- and moderate-income, historically disadvantaged communities impacted by COVID-19. In total, Congress provided a record $12 billion to the CDFI Fund. These resources will significantly enhance the work CDFIs are already doing in low-income communities. In FY 2020, CDFI Fund financial assistance recipients made over 1,000,000 loans or investments totaling more than $25.4 billion. [1] The average size of each loan or investment was under $25,000. CDFIs also financed over 41,000 affordable housing units. CDFI loans and investments include $10 billion for consumer loans, $6.5 billion for home improvement and purchase loans, $3.9 billion for business and microenterprise loans, and $2.2 billion for residential real estate transactions. CDFIs also helped ensure PPP resources reached underserved communities, but not without some changes to the program. The initial round of PPP left many economically distressed communities behind. In April 2020, the Coalition led the way to establish a set-aside for CDFIs and other mission-driven lenders – Community Financial Institutions (CFIs). Newly armed with a PPP set-aside, CFIs went to work. According to data from the Small Business Administration (SBA), as of May 31, 2021, CFIs had made 1.6 million PPP loans (21% of all PPP loans) for $34 billion in PPP funds (11% of PPP loan funds offered). Loans made through CFI lenders had an average PPP loan size of $21,254, compared to $41,560 across all lender classes, demonstrating the focus of CFI lending to small and micro-businesses. In addition, nearly 40% of CFIs’ loans reached businesses in low and moderate-income communities, compared to 28% across all lending sources. Both the Rapid Response Program and the PPP set-aside helped CDFIs expand their reach in communities hardest hit by the coronavirus. CDFIs are using these resources to promote job creation, business opportunities in low-income, minority, rural and tribal communities across America. [1] Audit of the CDFI Fund’s 2020 financial statements by the Treasury Dept. Office of Inspector General About the CDFI Coalition The CDFI Coalition is the unified national voice of community development financial institutions. Formed in 1992 as an ad-hoc policy development and advocacy initiative, the Coalition of Community Development Financial Institutions (CDFI Coalition) is the lead national organization in the United States promoting the work of community development financial institutions (CDFIs). Through its 150+ member organizations, the Coalition represents CDFIs working in all 50 states and the District of Columbia and includes community development loan funds, community development banks, community development credit unions, microenterprise lenders, community development corporations and community development venture capital funds. The CDFI Coalition coordinates industry-wide initiatives to increase the availability of capital, credit, and financial services to low-income communities across the nation. Read more at cdfi.org. Contact Details CDFI Coalition Greg Wilson +1 571-239-7474 greg@curleycompany.com Company Website https://cdfi.org/

June 16, 2021 03:12 PM Eastern Daylight Time

New high-tech health screening technology to detect COVID-19 symptoms

Ontario Tech University

As a research leader in the ethical deployment of new technologies, Ontario Tech University is working with data sensory and ‘Internet of Things’ (IoT) company SmartCone Technologies to test a high-tech system capable of real-time multi-symptom screening for COVID-19. Making sense of scent loss Loss of smell is a common indicator of COVID-19 infection. Various research studies show loss of smell affects anywhere between 80 and 96 per cent of COVID-19-positive patients. U.S. agencies such as the Centers for Disease Control and Prevention, and the National Institutes of Health recognize and recommend smell testing for COVID-19 screening. SmartCone’s anonymous, two-step web-based health-screening process, dubbed SYMP2PASS, combines COVID-19 sense-of-smell testing with smart kiosks, thermal scanners, and other technologies to provide private, speedy, and reliable COVID-19 screening without accessing personal information: At home: In the privacy of their own home, a person uses their smart device to scan the QR code located on the company’s SYMP2PASS scent test packet, completes the smell test, and answers additional screening questions. They receive immediate confirmation of test results. In public spaces: If the person passes the at-home pre-screening, they will receive another QR code that provides a 24-hour ‘Day Pass’ to enter a SYMP2PASS Smart Kiosk set up at the entry point to the public venue they wish to access. The kiosk has a thermal camera with a sensor that tests for fever. The kiosk also uses mask-image recognition to ensure anyone entering a location is wearing a mask. SmartCone has a federal research contract with Innovation, Science and Economic Development's (ISED) Innovation Solutions Canada Sector to develop the technology. SYMP2PASS benefits SmartCone estimates onsite point-of-entry screening can reduce COVID-19 spread by up to 75 per cent, making the system ideal for any business or high-traffic location, such as professional sports stadium or a major amusement park. SYMP2PASS will: Help organizations follow current and future screening requirements mandated by various levels of governments and health authorities. Collate data from all access points and in-home measurements to ensure employers meet all privacy regulations. Support workplace contact-tracing capabilities. Warn participants of positive test results. Provide access control for visitors/guests and employees. Quotes “A crucial role the Ontario Tech University research enterprise plays is supporting lab-to-market initiatives. Our collaboration with SmartCone and Innovation, Science and Economic Development Canada is an exemplar of this role and will be a model for future product research, testing and validation of new technologies.” - Dr. Les Jacobs, Vice-President, Research and Innovation, Ontario Tech University "Innovation, Science and Economic Development was instrumental in being able to demonstrate our ability to fight COVID. They were very professional, organized and easy to work with. SmartCone is now selling to U.S. companies as a direct result of the demonstration." - Jason Lee, CEO, SmartCone Technologies About SYMP2PASS Powered By SmartCone SYMP2PASS, developed in conjunction with doctors and researchers, is the first anonymous end-to-end advanced health screening web process. Using our patent pending ScentsiBLE scent test paired with multi-symptom survey, SYMP2PASS will help reduce the spread of COVID and save businesses and countries millions of dollars. Learn more at www.symp2pass.com About SmartCone Technologies, Inc. SmartCone Technologies Inc. (SCTI) is a unique data sensory company that commercializes new Internet-of-Things (IoT) technologies powering a wide array of sensors, edge computing, sensor fusion and artificial intelligence (AI). TheSmartCone™ solutions have been used most recently in " Return to Work " solutions during the COVID-19 pandemic, as well as securing dangerous work sites, controlling bicycle lane traffic, managing vehicle fleets, smart warehouses, crowd control, and more. Visit us at www.thesmartcone.com Contact Details Tenille Houston +1 613-617-7467 tenille@thesmartcone.com

June 16, 2021 02:30 PM Eastern Daylight Time

Image

Survey Says 66% Of California Independent Physicians Have Optimistic Outlook, While COVID-19 Pandemic Spurred Re-evaluation of Their Work Lives

Altais

While clinician burnout following the COVID-19 pandemic has been widely documented, a recent survey of independent physicians across California, conducted by Altais, in partnership with California Medical Association and Brown & Toland Physicians, indicates that, in California, the news is not all bad: 66% of respondents characterized as “very or somewhat optimistic” their general outlook and attitude looking to the future, vs. 20% who feel “very or somewhat pessimistic.” 65% reported experiencing “excellent or good” overall physical and mental health right now, vs. 14% reporting “fair or poor” overall health. At the same time, the survey made clear that the last 16 months of the pandemic have had an impact on how providers view their professional choices: 56% of respondents reported that a primary source of work-related stress during the pandemic was the overall financial performance of their practice; 42% named reduced patient visits as a primary stressor. 44% responded that the pandemic “changed how I think about work-life balance.” 35% reported that the pandemic “confirmed my commitment to independent practice,” while 25% said they “question my commitment to independent practice.” 35% reported that the pandemic “confirmed my commitment to practicing medicine,” while only 14% say they question that commitment. Telehealth and other technologies played a significant role in helping physicians and patients navigate the pandemic, and they appear to be a permanent part of healthcare’s future. Respondents confirmed this shift as follows: 30% responded that the past year “made me want to use technology more to see my patients.” 47% had not previously used telehealth to see patients. 39% responded that telehealth “played a crucial role in my ability to continue to care for patients.” 46% see telehealth as “a staple” of future practice. 4% reported that telehealth “did not work for my practice” According to Medscape’s 2021 Physician Burnout & Suicide Report, 42% of physicians reported feeling burnout in 2020. “We’ve known about the challenge of physician burnout for a long time,” said Dr. Jeff Bailet, CEO of Altais. “Pressures are particularly keen for independent physicians, which is why Altais’ mission is to create business systems and solutions specifically for them. Physician gratification is the critical fourth element of healthcare’s quadruple aim. We’re encouraged by the survey respondents’ increased optimism and renewed commitment to the practice of medicine. At the same time, we hear their need for more support loud and clear.” Survey methodology and respondents The survey was conducted online, shared via email with 9,564 independent physicians throughout California, in April and May 2021. About the 318 respondents: Geographic distribution: 51% are located in the greater San Francisco Bay Area; 18% in the greater Los Angeles area; 11% in greater San Diego and 20% distributed throughout the rest of the state. Type of medical practice: 58% are a specialty practice; 42% are primary care. Size of practice: 83% are in small/solo practice (fewer than 10 practitioners). About Altais Altais is a healthcare services company that helps physicians and the clinical community maximize the health and well-being of their patients in an affordable and sustainable way. Altais has two divisions. Altais Clinical Services offers a range of affiliation and employment models for physicians, and high-quality, affordable care for patients. Altais Health offers a broad platform of clinical support tools and technology, along with high-touch support. Altais seeks to enhance the vibrancy of physician practice and strengthen the heart of medicine – physicians connecting with patients and providing personalized, high-quality care. For more information about Altais, please visit www.altais.com. Editors, please note: Photos and interviews are available by contacting Robin Carr at (415) 971-3991 or Altais@landispr.com. Contact Details Landis Communications Inc. Robin Carr +1 415-971-3991 altais@landispr.com Company Website https://altais.com/

June 16, 2021 06:22 AM Pacific Daylight Time

NHS Test and Trace strengthen their cyber defences with Risk Ledger

Stockwood Strategy

NHS Test and Trace has selected British cyber security company Risk Ledger to manage cyber security risks in their supply chain as a proactive measure to mitigate the increasing risks the NHS and other critical national infrastructure organisations face from supply chain cyber-attacks. The Risk Ledger platform will give the UK government funded service all the tools they need to manage cyber security risks in their supply chain at speed for a low per-supplier cost - at least 60% cheaper than traditional solutions. Cyber security risks in the supply chain can include third parties failing to encrypt sensitive data when it is being transferred. NHS Test and Trace, established to track and help prevent the spread of the COVID-19 virus in England, will take advantage of Risk Ledger's key innovation which is its secure 'social network' allowing organisations to connect and share risk data securely, quickly, and easily. This gives organisations like NHS Test and Trace unparalleled visibility of their supply chain and a comprehensive set of data to identify, measure and mitigate supply chain security risks at scale. Major supply chain cyber security breaches at Solarwinds and Microsoft in recent months have put the challenge of securing supply chains at the top of the agenda for organisations around the world. Minister for Digital Infrastructure, Matt Warman MP said: “The government is working tirelessly to secure the nation online and grow the UK's £8.9 billion cyber security industry as we build back better from the pandemic. We're helping SMEs develop innovative products and services and it's great to see Risk Ledger, one of the firms we've supported, win this contract to protect the Test and Trace system and support the national effort against coronavirus.” Risk Ledger's client base includes organisations like BAE AI, City of London Police, Telenor, Schroder's Personal Wealth and ASOS. Risk Ledger CEO and Co-Founder Haydn Brooks said: "NHS Test and Trace is essentially the biggest new start-up in the UK healthcare market so we are delighted they have chosen to take advantage of our ability to provide enhanced visibility of their supply chain risks. I am proud we will be part of the effort to secure this incredibly important supply chain. "Healthcare organisations and their supply chains handle lots of highly sensitive data and have a high rate of data breaches. We have already seen during the COVID-19 pandemic that bad actors are actively targeting supply chains to access data and cause disruption” added Haydn Brooks. Risk Ledger is a rising star of the UK's growing cyber security scene having won competitions run by the UK Government's National Cyber Security Centre, the tech industry body TechUK and most recently a winner in the Department for Digital, Culture, Media, and Sport’s ‘Most Innovative UK Cyber SME of the Year’ competition in May. The company is also a member of the UK Government backed LORCA programme (London Office of Rapid Cybersecurity Advancement). About Risk Ledger Risk Ledger is a British company that manages cyber security risks in supply chains. Th process of supply chain security risk management ensures third parties who deliver critical services, have access to data, corporate networks, or any other status of business trust, maintain a good base level of cyber security controls to prevent bad actors using the third party as an attack vector. In 2019, Risk Ledger won the ‘Cyber Den’ competition at the 2019 CyberUK event run by the UK Government’s National Cyber Security Centre (NCSC) and the Department for Digital, Culture, Media and Sport (DCMS). At the time, Ian Levy, Technical Director at the NCSC said: ‘Our mission is to make the UK the safest place to do business online. We run the Cyber Den competition with DCMS to identify and provide a springboard for the most promising cyber security start-ups in the UK. Risk Ledger beat some excellent competition at this year’s Cyber Den event because their platform approaches supply chain security in a novel way that could revolutionise the way organisations understand the cybersecurity of their supply chains which is at the root of so many security incidents.’ Notable achievements - Risk Ledger was a finalist in the 'Most Innovative New Technology Award' category at the 2021 Water Industry Awards. - In March 2021, Risk Ledger won the South Summit Industry 4.0 innovation competition. - In May 2021, Risk Ledger was announced as a runner up in the Department for Digital, Culture, Media, and Sport’s ‘Most Innovative UK Cyber SME of the Year’ competition. Contact Details Risk Ledger Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://riskledger.com/

June 16, 2021 05:15 AM Eastern Daylight Time

Image

Living Kidney Donor Receives National Advocacy Award

United Network for Organ Sharing

Today, the United Network for Organ Sharing (UNOS), the mission-driven nonprofit serving as the nation’s transplant system, announced the recipient of the 2021 National Donor Memorial Award for Excellence: Jon Lee, who donated one of his kidneys as part of a paired organ exchange at Medical City Dallas in Texas. UNOS established the National Donor Memorial Award for Excellence in 2010 to annually recognize exceptional advocates for organ and tissue donation. “Becoming a living donor is one of the most profound and transformative decisions someone can make,” said UNOS President David Mulligan, M.D. “Jon is the first living donor to receive this award and an inspiring example of what it means to give the gift of life. With his ongoing outreach to encourage more people to become living kidney donors, Jon Lee truly embodies the spirit of this award.” Previous award winners have included organ recipients, donor family members and a social worker. Lee became a living organ donor because his brother-in-law needed a transplant. In 2019, living donors made possible almost 30% of all kidney transplants performed nationwide. Lee, a 41-year-old husband and father from McKinney, Texas says that donating his kidney in August of 2019 was such a life-changing and spiritually fulfilling experience that he started the “Us For Them” movement with a mission to eliminate the kidney transplant waitlist. His goal is to “inspire people of faith to prayerfully consider living kidney donation.” His efforts have included developing a website, UsForThem.org, that provides information, data and facts about living kidney donation, inspirational videos and an opportunity for people to consider becoming a kidney donor. A Facebook page also provides a channel to enable donors and recipients to share their stories. As a result of these efforts, multiple potential donors have now begun the living donor evaluation process. "Jon Lee's passionate advocacy for organ donation exemplifies Medical City Healthcare's commitment to the care and improvement of human life," said Medical City Dallas Solid Organ Transplant Director Emilie Burgess, who nominated Lee for the UNOS award. "In 2020, the collaborative transplant programs at Medical City Dallas and Medical City Fort Worth performed 277 solid organ transplants, and Jon's outreach to potential donors can help make kidney transplantation a reality for so many more people in need of this lifesaving gift." After Lee decided to give a kidney to his brother-in-law, Jason Smith, Lee found out he was not a compatible match to donate directly. However, Lee was still able to help Smith receive a transplant through a paired kidney exchange coordinated by the transplant programs at Medical City Dallas and Medical City Fort Worth. A paired kidney exchange works this way: Many patients in need of a kidney have family members or friends willing to donate. But a patient and a potential donor must go through a series of tests, and sometimes a patient has a willing donor who is not an acceptable match. Transplant hospitals and paired kidney donation programs can identify and connect these non-matching pairs of patients and donors, so that the recipients end up with an organ that’s a match for them. Through this kind of “swap,” Lee’s kidney was transplanted into Jill Kolb of Fort Worth at Medical City Fort Worth, and Smith received a kidney from Kolb’s close friend Sara Holloway at Medical City Dallas. ### About United Network for Organ Sharing (UNOS) United Network for Organ Sharing (UNOS) is the mission-driven nonprofit serving as the nation’s transplant system under contract with the federal government. We lead the network of transplant hospitals, organ procurement organizations, and thousands of volunteers who are dedicated to honoring the gifts of life entrusted to us and to making lifesaving transplants possible for patients in need. Working together, we leverage data and advances in science and technology to continuously strengthen the system, increase the number of organs recovered and the number of transplants performed, and ensure patients across the nation have equitable access to transplant. About Medical City Dallas Medical City Dallas is an 876-bed, acute care hospital located in Dallas, Texas. With a medical team of more than 1,700 providers, many of whom are top experts in their fields, Medical City Dallas offers nearly 100 specialties, including world-class programs for heart and vascular, brain and spine, women’s services, orthopedics, transplant (heart, kidney and pancreas), cancer, bariatrics and robotic surgery. Voted “Best Place to Have a Baby” in Dallas County by DFW Child readers, more than 4,000 babies are delivered annually at its dedicated women’s hospital, Medical City Women’s Hospital Dallas, which includes a Level IV neonatal ICU (NICU). “A” rated for safety by the Leapfrog Group and Magnet® recognized for nursing excellence. Medical City Dallas is part of Medical City Healthcare. Contact Details United Network for Organ Sharing Anne Paschke +1 804-782-4730 anne.paschke@unos.org Medical City Dallas Kelly Hanes Kelly.Hanes@MedicalCityHealth.com Company Website https://unos.org

June 15, 2021 12:47 PM Eastern Daylight Time

Image

1 ... 270 271 272 273 274 ... 307